151 related articles for article (PubMed ID: 36231119)
1. Calcium-Related Genes Predicting Outcomes and Serving as Therapeutic Targets in Endometrial Cancer.
Huang T; Feng X; Wang J; Zhou J; Wang J
Cells; 2022 Oct; 11(19):. PubMed ID: 36231119
[TBL] [Abstract][Full Text] [Related]
2. Identification of a metabolism-related gene expression prognostic model in endometrial carcinoma patients.
Jiang P; Sun W; Shen N; Huang X; Fu S
BMC Cancer; 2020 Sep; 20(1):864. PubMed ID: 32894095
[TBL] [Abstract][Full Text] [Related]
3. Development and Validation of a Five-immune Gene Pair Signature in Endometrial Carcinoma.
Li N; Yu K; Lin Z; Zeng D
Comb Chem High Throughput Screen; 2021; 24(2):233-245. PubMed ID: 32729416
[TBL] [Abstract][Full Text] [Related]
4. Establishing a Prognostic Signature Based on Epithelial-Mesenchymal Transition-Related Genes for Endometrial Cancer Patients.
Liu J; Cui G; Shen S; Gao F; Zhu H; Xu Y
Front Immunol; 2021; 12():805883. PubMed ID: 35095892
[TBL] [Abstract][Full Text] [Related]
5. Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma.
Lai J; Xu T; Yang H
BMC Cancer; 2022 Mar; 22(1):325. PubMed ID: 35337291
[TBL] [Abstract][Full Text] [Related]
6. Construction of a microenvironment immune gene model for predicting the prognosis of endometrial cancer.
Wang Y; Zhang J; Zhou Y; Li Z; Lv D; Liu Q
BMC Cancer; 2021 Nov; 21(1):1203. PubMed ID: 34763648
[TBL] [Abstract][Full Text] [Related]
7. Significance of a PTEN Mutational Status-Associated Gene Signature in the Progression and Prognosis of Endometrial Carcinoma.
Wu Y; Wang J; Ge L; Hu Q
Oxid Med Cell Longev; 2022; 2022():5130648. PubMed ID: 35251475
[TBL] [Abstract][Full Text] [Related]
8. Calcium and calcium-related proteins in endometrial cancer: opportunities for pharmacological intervention.
Huang T; Zhou J; Wang J
Int J Biol Sci; 2022; 18(3):1065-1078. PubMed ID: 35173539
[TBL] [Abstract][Full Text] [Related]
9. An integrated autophagy-related gene signature predicts prognosis in human endometrial Cancer.
Zhang J; Wang Z; Zhao R; An L; Zhou X; Zhao Y; Wang H
BMC Cancer; 2020 Oct; 20(1):1030. PubMed ID: 33109128
[TBL] [Abstract][Full Text] [Related]
10. A novel chromatin regulator-related immune checkpoint related gene prognostic signature and potential candidate drugs for endometrial cancer patients.
Liu Z; Yang H; Chen Z; Jing C
Hereditas; 2022 Oct; 159(1):40. PubMed ID: 36253800
[TBL] [Abstract][Full Text] [Related]
11. A four-miRNA signature as a novel biomarker for predicting survival in endometrial cancer.
Wu YS; Lin H; Chen D; Yi Z; Zeng B; Jiang Y; Ren G
Gene; 2019 May; 697():86-93. PubMed ID: 30779946
[TBL] [Abstract][Full Text] [Related]
12. Novel insights into tumorigenesis and prognosis of endometrial cancer through systematic investigation and validation on mitophagy-related signature.
Sun R; Zhou X; Wang T; Liu Y; Wei L; Qiu Z; Qiu C; Jiang J
Hum Cell; 2023 Jul; 36(4):1548-1563. PubMed ID: 37266867
[TBL] [Abstract][Full Text] [Related]
13. Progesterone induces cell apoptosis via the CACNA2D3/Ca2+/p38 MAPK pathway in endometrial cancer.
Kong X; Li M; Shao K; Yang Y; Wang Q; Cai M
Oncol Rep; 2020 Jan; 43(1):121-132. PubMed ID: 31746409
[TBL] [Abstract][Full Text] [Related]
14. TTK, CDC25A, and ESPL1 as Prognostic Biomarkers for Endometrial Cancer.
Yang Q; Yu B; Sun J
Biomed Res Int; 2020; 2020():4625123. PubMed ID: 33282948
[TBL] [Abstract][Full Text] [Related]
15. Construction of a nine DNA repair-related gene prognostic classifier to predict prognosis in patients with endometrial carcinoma.
Liu J; Jiang P; Chen X; Shen Y; Cui G; Ma Z; Zhao S; Zhang Y
BMC Cancer; 2021 Jan; 21(1):29. PubMed ID: 33407221
[TBL] [Abstract][Full Text] [Related]
16. Hsa-microRNA-181a is a regulator of a number of cancer genes and a biomarker for endometrial carcinoma in patients: a bioinformatic and clinical study and the therapeutic implication.
He S; Zeng S; Zhou ZW; He ZX; Zhou SF
Drug Des Devel Ther; 2015; 9():1103-75. PubMed ID: 25733820
[TBL] [Abstract][Full Text] [Related]
17. Identification of prognostic immune-related genes in the tumor microenvironment of endometrial cancer.
Chen P; Yang Y; Zhang Y; Jiang S; Li X; Wan J
Aging (Albany NY); 2020 Feb; 12(4):3371-3387. PubMed ID: 32074080
[TBL] [Abstract][Full Text] [Related]
18. Clinical significance of Sam68 expression in endometrial carcinoma.
Wang Q; Li Y; Zhou J; Liu J; Qin J; Xing F; Zhang J; Cheng J
Tumour Biol; 2015 Jun; 36(6):4509-18. PubMed ID: 25874492
[TBL] [Abstract][Full Text] [Related]
19. An eleven autophagy-related genes-based prognostic signature for endometrial carcinoma.
Li S; Pan J; Zhang Y; Tang Y; Zeng X; Wang S; Wu D; Liu Y; Xu D; Lan J; Hu D
J Egypt Natl Canc Inst; 2022 Oct; 34(1):42. PubMed ID: 36210389
[TBL] [Abstract][Full Text] [Related]
20. miR-944 acts as a prognostic marker and promotes the tumor progression in endometrial cancer.
He Z; Xu H; Meng Y; Kuang Y
Biomed Pharmacother; 2017 Apr; 88():902-910. PubMed ID: 28178620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
